Seres Therapeutics Inc (NAS:MCRB)
$ 0.9577 -0.09 (-8.57%) Market Cap: 145.94 Mil Enterprise Value: 298.35 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Seres Therapeutics, Inc. - Special Call Transcript

May 27, 2020 / 12:30PM GMT
Release Date Price: $5.75 (-7.18%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Seres SER-109 Investor Event Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Eric Shaff, CEO. Thank you. Please go ahead, sir.

Eric D. Shaff
Seres Therapeutics, Inc. - President, CEO & Director

Good morning, and welcome to Seres Therapeutics SER-109 Investor Day. Thank you for spending time with us this morning. This is an important moment for Seres and for the microbiome space in general. We believe that our upcoming SER-109 Phase III readout will be the catalyst to demonstrate that the microbiome has moved from an emerging treatment modality to one that is here now. Our primary goal for today is to provide you with information that will enable you to better understand and appreciate our pending SER-109 Phase III results, which we are expecting this summer.

Now we will be making forward-looking statements in today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot